Acadia Pharmaceuticals (ACAD) Stock: Here’s What You Need To Know!

Acadia Pharmaceuticals (NASDAQ:ACAD) On Monday, Acadia Pharmaceuticals announced that it had initiated a phase 2 trial in patients with Alzheimer’s Disease Agitation. Once again ACAD will use its drug Pimavanserin to see if the drug will work in this targeted indication. The company has already received FDA approval for Pimavanserin in Parkinson’s Disease Psychosis. Now … Read more

Biotech Stock News (ACAD) (CUR) (AMRN)

Acadia Pharmaceuticals (ACAD) Shares of Acadia Pharmaceuticals tanked around 30% in after hours trade on 3/11/15 after it had announced two different sets of news. The first set of news was that the CEO of Acadia Uli Hacksell would not only be stepping down as the CEO of the company but stepping down from the … Read more